Vimseltinib - HY-136256
Nur noch %1 verfügbar
Catalog #
HY-136256
Ab
258,00 €
Vimseltinib (DCC-3014) is a c-FMS (CSF-IR) and c-Kit dual inhibitor extracted from patent WO2014145025A2, Compound Example 10, has IC50s of [1].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-136256/Vimseltinib-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | Cancer-Kinase/protease |
| Alternative Names | DCC-3014 |
| CAS | 1628606-05-2 |
| Storage | -20°C, 3 years; 4°C, 2 years (Powder) |
| MWT | 431.49 |
| Solubility | DMSO : 50 mg/mL (ultrasonic;warming;heat to 60°C) |
| Clinical Information | Launched |
| Target | c-Fms;c-Kit |
| Application: | Cancer-Kinase/protease |
|---|